In the last trading session, 3.34 million FibroBiologics Inc (NASDAQ:FBLG) shares changed hands as the company’s beta touched -0.63. With the company’s per share price at $0.62 changed hands at -$0.09 or -13.19% during last session, the market valuation stood at $23.65M. FBLG’s last price was a discount, traded about -877.42% off its 52-week high of $6.06. The share price had its 52-week low at $0.69, which suggests the last value was -11.29% down since then. When we look at FibroBiologics Inc’s average trading volume, we note the 10-day average is 0.65 million shares, with the 3-month average coming to 249.98K.
FibroBiologics Inc (NASDAQ:FBLG) trade information
Instantly FBLG was in red as seen at the end of in last trading. With action -11.14%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -87.64%, with the 5-day performance at -11.14% in the red. However, in the 30-day time frame, FibroBiologics Inc (NASDAQ:FBLG) is -20.03% down. Looking at the short shares, we see there were 1.35 million shares sold at short interest cover period of 5.08 days.
The consensus price target for the stock as assigned by Wall Street analysts is 9, meaning bulls need an upside of 93.11% from its current market value. According to analyst projections, FBLG’s forecast low is 9 with 9 as the target high. To hit the forecast high, the stock’s price needs a -1351.61% plunge from its current level, while the stock would need to soar -1351.61% for it to hit the projected low.
The 2025 estimates are for FibroBiologics Inc earnings to decrease by -28.85%, but the outlook for the next 5-year period is at -14.51% per year.
FBLG Dividends
FibroBiologics Inc is expected to release its next quarterly earnings report on 2025-May-14.
FibroBiologics Inc (NASDAQ:FBLG)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 21.42% of FibroBiologics Inc shares while 16.86% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 21.46%. There are 16.86% institutions holding the FibroBiologics Inc stock share, with FUND EVALUATION GROUP, LLC the top institutional holder. As of 2024-06-30, the company held 3.2247% of the shares, roughly 1.06 million FBLG shares worth $5.26 million.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 2.8086% or 0.92 million shares worth $4.59 million as of 2024-06-30.
